Operating Officer & General Manager of Basic Research, Otsuka Pharmaceutical Co., Ltd.
From 2011 through January 2015, Dr. Shiratsuchi was Chief Operating Officer and then Chief Executive Officer of Otsuka Maryland Medicinal Laboratories (OMML), Otsuka’s main research institute in the U.S. Earlier, Dr. Shiratsuchi was a researcher and a director in various research institutes at Otsuka. His research and managerial engagement spanned oncology, immunology, vaccinology, molecular biology and genetics.
At the University of Tokyo, Dr. Shiratsuchi earned a bachelor’s degree, a master’s degree from the Graduate School of Pharmaceutical Sciences and a Ph.D. from the Graduate School of Medicine.